Ocugen Inc. has approved an additional award of 9,369,604 Performance Restricted Stock Units (PSUs) for Chief Executive Officer Dr. Shankar Musunuri. This award, set to be granted on January 2, 2026, comes in addition to Dr. Musunuri’s regular annual equity award. The PSUs are subject to a three-year performance period ending December 31, 2028, and will vest based on the achievement of specific regulatory and stock performance milestones. Two-thirds of the PSUs will vest upon reaching regulatory milestones, while the remaining third will vest upon achieving a stock performance milestone. Unvested PSUs will be forfeited if the milestones are not met by the end of the performance period or upon termination of service.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocugen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-122610), on December 18, 2025, and is solely responsible for the information contained therein.
Comments